FDA Inspection 905859 — Coastal Meds, LLC

Coastal Meds, LLC — FEI 3005180755

The FDA completed an inspection of Coastal Meds, LLC on November 10, 2014 in Biloxi, MS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 10, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Biloxi, MS (United States)

Citations

IDCFRDescription
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
141621 CFR 211.42(c)(6)Pkg / Labeling Operations Area
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
144821 CFR 211.111Establishment of time limitations
145221 CFR 211.113(b)Validation lacking for sterile drug products
176721 CFR 211.137(a)Expiration date lacking
191421 CFR 211.166(a)Lack of written stability program
193221 CFR 211.167(a)Sterility/pyrogen-free testing
202721 CFR 211.192Investigations of discrepancies, failures